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Environmental estrogenic chemicals such as bisphenol A and nonylphenol, which are contained in many industrial products, can be detected in foods, tap water, and many environmental materials. Nonylphenol is used in a wide variety of detergents and plastics and has been reported to be environmentally persistent (White et al., 1994) . The mean daily oral intake of nonylphenol by humans is estimated to be 0.16 mg/day (Muller et al., 1998) . Nonylphenol has been shown to be a possible endocrine disrupter due to its estrogenic effects in MCF7 cell proliferation assays (Soto et al., 1991) , binding assays to the estrogen receptor (White et al., 1994) and uterotropic assays in mice (Shelby et al., 1996) . Exposure of male rainbow trout (Oncorhynchus mykiss) to four different alkylphenolic chemicals, including nonylphenol, resulted in synthesis of vitellogenin, a process normally dependent on endogenous estrogens, and a concomitant inhibition of testicular growth (Jobling et al., 1996) . Male and female ratios of Japanese medaka (Oryzias latipes) in a control group (2:1) and a 100 g/l nonylphenol treatment group (1:2) were reported to be significantly different (Gray and Metcalfe, 1997) . Early neonatal exposure to nonylphenol has been reported to cause dysfunction of postpubertal reproductive function in female rats as well as disrupted development of gonads in male and female rats (Nagao et al., 2000) . It has also been reported that nonylphenol administered orally at a dose of 50 mg/kg of body weight induced a significant increase in uterine weight of prepubertal rats and advanced the age of vaginal opening (Laws et al., 2000) . Elucidation of the metabolism and fate of nonylphenol is important for estimating the risks of the chemical for animals. Xenoestrogens such as bisphenol A and diethylstilbestrol have been shown to be conjugated with glucuronic acid by a UDPglucuronosyltransferase isoform, UGT2B1, in the rat liver (Yokota et al., 1999) . Nonylphenol has also been reported to be glucuronidated extensively in the liver of animals such as rainbow trout (Lewis and Lech, 1996; Coldham et al., 1998; Thibaut et al., 1998a,b) and rats (Moffat et al., 2001; Yokota et al., 2002) . Since the liver is the main barrier against drugs in the body, identifying or tracing the metabolites of nonylphenol is important for elucidation of the disruptive effects of the compound on the reproductive system.
In this study, we investigated the metabolism and kinetics of nonylphenol and those of other alkylphenols by means of liver perfusion, and we found that nonylphenol was delayed in excretion from the liver and that the length of the alkyl chain is a critical factor for the excretion rate and route out of the liver.
the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health in the United States.
Expression of UDP-Glucuronosyltransferase 2B1. cDNA of rat UDPglucuronosyltransferase isoform UGT2B1 was obtained by reverse transcriptase-polymerase chain reaction and expressed in yeast AH22 cells as previously described (Yokota et al., 1999) . Nonylphenol glucuronidation was performed using yeast microsome-expressed UGT2B1, and the resultant glucuronide conjugate was analyzed by HPLC as described previously (Yokota et al., 1999) .
Surgical Procedure. The rats were anesthetized by intraperitoneal injection of 60% urethane (0.3 ml/100 g of body weight). Whole liver perfusion was performed according to the method reported by Sugano et al. (1978) with slight modifications (Inoue et al., 2001) . Briefly, after anesthesia, the abdomen was opened and the liver, portal vein, bile duct, and inferior vena cava were exposed. The common bile duct and the portal vein were cannulated with PE-10 and PE-50 polyethylene tubes (BD Biosciences, San Jose, CA), respectively, and oxygenated Krebs-Ringer buffer, described below, was pumped through the liver via the portal vein. The abdominal vena cava was incised immediately after perfusion, and a dripping polyethylene tube (2 mm i.d., 3 mm o.d.) was inserted. The thorax was then opened and the thoracic vena cava was ligated. The liver was not excised. All experiments were performed in situ. While the animals were still under anesthesia, euthanasia was performed by exsanguination.
Liver Perfusion. Krebs-Ringer buffer (115 mM NaCl, 5.9 mM KCl, 1.2 mM MgCl 2 , 1.2 mM NaH 2 PO 4 , 1.2 mM Na 2 SO 4 , 2.5 mM CaCl 2 , 25 mM NaHCO 3 , 10 mM glucose) was used in all experiments. The buffer solution was aerated by 95% O 2 ϩ 5% CO 2 , and the pH was adjusted to 7.4. Ethanol containing alkylphenol was dispersed into the buffer solution, and final concentration of ethanol was 1%. The substrate buffer solution contained alkylphenol in a final concentration of 0.025 or 0.05 mM. These buffer solutions were maintained in a water bath at 37°C. The perfusion system consisted of a peristaltic pump (MP-32N; EYELA, Tokyo Rikakikai Co. Ltd., Tokyo, Japan) and silicone tubes, as described in our previous paper (Inoue et al., 2001 ). The buffer solution was pumped at a constant rate of 30 ml/min, and the liver perfusion was carried out in a flow-through mode. Preliminary perfusion was done for 15 min, and then the substrate buffer solution was perfused for 5 min, followed by reperfusion of the Krebs-Ringer solution. After perfusion of the substrate buffer, the excreted bile and perfusate in the vein were collected at 5-min or 10-min intervals over a 1-h period.
HPLC Analysis of Reaction Products. The bile was dissolved in 40-fold 50% acetonitrile, and perfusate was diluted with an equal volume of acetonitrile; then, the perfusate mixtures were centrifuged for 10 min at 10,000g. The supernatant fractions were analyzed by HPLC (Shimadzu, Tokyo, Japan) according to the method described previously (Yokota et al., 1999; Inoue et al., 2001) . Alkylphenols and its metabolites were eluted from HPLC by 75% acetonitorile solution (acetonitrile/water/acetic acid, 75:25:0.1) for nonylphenol, 60% solution for hexylphenol, 50% solution for butylphenol, and 35% solution for ethylphenol. Recordings were made using a C-R8A integrator (Shimadzu, Tokyo, Japan). Alkylphenols and its metabolites retained in the liver after the perfusion were extracted with acetonitrile, the extractions were centrifuged for 30 min at 25,000g, and the supernatants were analyzed by HPLC with the same procedure described above. Alkylphenol-glucuronides were quantitated by the amount of the deconjugated free alkylphenols after ␤-glucuronidase treatment of the reaction products as previously described (Shibata et al., 2002).
FIG. 1. HPLC profiles of nonylphenol metabolites after liver perfusion and glucuronide conjugate of nonylphenol produced by UDP-glucuronosyltransferase UGT2B1.
The liver was perfused for 60 min with Krebs' solution as a control (A). Nonylphenol perfusion was performed with the same buffer containing 0.050 mM nonylphenol for 5 min and then perfused with Krebs buffer for 55 min (B). Nonylphenol and its metabolites in the liver were extracted with acetonitrile and then analyzed by HPLC after the perfusion as described under Materials and Methods. The UDP-glucuronosyltransferase isoform UGT2B1 was expressed in yeast AH22 cells, and nonylphenol was glucuronidated by microsomes prepared from the yeast transformant as described under Materials and Methods. The enzyme reactions were performed for 0 min (C) and 60 min (D), and the resultant glucuronide produced by UGT2B1 was analyzed by HPLC. The arrows indicate NP-G and unconjugated nonylphenol (NP).
FIG. 2. UDP-glucuronosyltransferse activities in rat liver microsomes toward various alkylphenols.
The alkylphenols, ethylphenol (C2), butylphenol (C4), hexylphenol (C6), and nonylphenol (C9), were incubated with rat liver microsomes, which was activated by sodium cholate in the presence of UDP-glucuronic acid. UDP-glucuronosyltransferase activities were determined by HPLC analysis as described under Materials and Methods. Parameters are shown as means Ϯ S.E. (n ϭ 3 animals). 
Results
The HPLC profiles of the metabolites of nonylphenol produced in the liver, after the perfusion had been performed as described under Materials and Methods, are shown in Fig. 1 . The nonylphenol metabolite extracted from the perfused liver was eluted at an early retention time as a single peak [nonylphenol-␤-D-glucuronide (NP-G); 7 min] with slight shoulder peaks (Fig. 1B) . The main peak produced by liver microsomes had the same retention time and was reduced by treatment with ␤-glucuronidase as was previously reported in rainbow trout (Lewis and Lech, 1996; Coldham et al., 1998; Thibaut et al., 1998a,b) (data not shown). A glucuronide conjugate of nonylphenol was produced by UGT2B1 (Fig. 1D) , indicating that the main metabolite in the liver perfusion is NP-G. The peak of NP glucuronide was confirmed to be not produced by AH22 yeast microsomes, expressing no UGT2B1, and in the enzyme reactions where the substrate was omitted. The K m value of the microsomal UDP-glucuronosyltransferase was estimated to be 0.25 mM nonylphenol. UDP-glucuronosyltransferase activities (V max ) toward nonylphenol and other alkylphenols in rat liver microsomes were assayed, and the estimated enzymatic activities are shown in Fig. 2 . UDP-glucuronosyltransferase activity toward nonylphenol showed about the same value as that of ethylphenol. These alkylphenols were injected into the portal veins of rats, and then the bile and perfusate in the veins were sampled and analyzed by HPLC as previously described (Inoue et al., 2001 ). The resultant metabolites of alkylphenols were mainly glucuronide conjugates (data not shown), as was the case for nonylphenol. The concentrations of the glucuronide conjugates of alkylphenols in the bile and vein during liver perfusion are shown in Fig. 3 . After the liver perfusion, alkylphenol-glucuronides were excreted only into the bile (Fig. 3, A-D) , and only ethylphenol-glucuronide was excreted into (Fig. 3E) . When 0.05 mM butylphenol and hexylphenol were perfused, these alkylphenols were also glucuronidated in the liver, but these glucuronides were not excreted completely from the liver within 60 min of perfusion (Fig.  3B) . Trace amounts of nonylphenol-glucuronide were detected only in the bile (Fig. 3, C and D) . The alkylphenols remaining in the livers after 1 h of perfusion were extracted as described under Materials and Methods. The amounts of alkylphenols in the liver and that excreted into bile and vein during 1 h of perfusion are shown in Fig. 4 . Recovery of alkylphenols after the perfusions were about 50 to 60% (Fig. 4) . One of the reasons for this is that it was supposed that all other alkylphenol metabolites such as hydroxylated alkylphenols and conjugated alkylphenols with sulfate or glutathione remaining in the liver tissue were not extracted with acetonitrile completely, and/or FIG. 4 
. Alkylphenol metabolites in the bile, liver tissue, and vein after 1 h of perfusion in SD rats.
Total amounts of alkylphenols and glucuronide conjugates, which were excreted into the bile and vein and remained in the liver during a 60-min period of liver perfusion, are shown. Numerals in the columns indicate the percentages of respective metabolites, free (Ⅺ) or glucuronide conjugate (u). Data are represented in the upper box (A) when 0.025 mM alkylphneol was injected, in the lower box (B) when 0.050 mM nonylphenol was injected. About 30% of injected alkylphenols were absorbed to the inside of the silicon tubes during the perfusions. Recovery was calculated with the tube absorption of each alkylphenol. Parameters are shown as means Ϯ S.E. (n ϭ 4 animals or n ϭ 3 animals in ethylphenol analysis).
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at ASPET Journals on June 8, 2017 dmd.aspetjournals.org these metabolites were not detected in this HPLC system. Unconjugated alkylphenols remained in the liver tissue, and small amounts of free alkylphenols were detected in the bile (Fig. 4) . About 800 to 1000 nmol of injected nonylphenol could be conjugated as a glucuronide by the rat liver within 1 h of perfusion, but most of the glucuronide and free nonylphenol remained in the liver (Fig. 4) . Other alkylphenols having shorter alkyl chains were excreted smoothly into the bile as glucuronides (Fig. 4) . These results indicated that alkylphenols with shorter (including C6) alkyl chains were easily excreted into the bile as glucuronides and that only the glucuronide conjugate of nonylphenol, which has a longer C9 alkyl chain, was not easily excreted from the liver. The metabolites of butylphenol and hexylphenol in liver perfusion of EHBR, which are deficient in xenobiotic conjugates transporter MRP-2, are shown in Fig. 5 . These alkylphenols were excreted into the vein as glucuronides, and only slight amounts of the metabolites were observed in the bile (Fig. 5A) . Rapid excretion and clearance of butylphenol-glucuronide from the liver were observed (Fig. 5, A and B) . The cumulative biliary excretion of the alkylphenolglucuronides, which were produced in the liver, was severely impaired in EHBR compared with SD rats, indicating that alkylphenolglucuronides were transported to the bile by MRP-2.
Discussion
The disposition of alkylphenols and their metabolites was investigated in SD rats and EHBR by a liver perfusion method. To determine the effects of nonylphenol on animals, it is essential to elucidate the metabolic fate of this compound. Various data on the metabolism and disposition of nonylphenol in fishes are available. The major metabolite (about half of the injected nonylphenol) in rainbow trout (O. mykiss) was excreted as a glucuronide conjugate of nonylphenol (Thibaut et al., 1998a,b) , and other metabolites, including glucuronide conjugates of ring-or side chain-hydroxylated nonylphenol (Coldham et al., 1998) , were detected. It has been reported that nonylphenol was extensively metabolized to the glucuronide conjugate in rats (Moffat et al., 2001; Doerge et al., 2002) . Doerge et al. (2002) have reported that two glucuronide metabolites (NP-glucuronide and p-nonyl-catechol glucuronide) were detected in the rat liver and serum after oral administration. We detected NP-glucuronide as a major peak with slight shoulder peaks after the liver perfusion. Other metabolites may be contained in the shoulder peaks. In this study, rat hepatocytes showed a significant capability for glucuronidation of nonylphenol of about 800 to 1000 nmol/h by liver perfusion, but the transport of the nonylphenol-glucuronide across the canalicular membrane into the bile was delayed. These findings suggest that nonylphenol glucuronidation is mediated by UDP-glucuronosyltransferase isoform(s), such as UGT2B1, with high activity but that the resultant glucuronide having a long (C9) alkyl chain could not be transported by MRP-2.
The substrate specificity of MRP-2 has been studied by comparing the transportation activity across the bile canalicular membrane in normal rats with that in transport-deficient rats (Paulusma et al., 1996) or in EHBR, which have a hereditary defect in MRP-2 (FernandezCheca et al., 1992; Takenaka et al., 1995; Yamazaki et al., 1996) . It has been demonstrated that glutathione conjugates, glucuronides of xenobiotics, sulfates of several bile acids, and some organic anions are substrates for MRP-2, but the mechanism of the transport and the substrate specificity of the transporter have not been clarified yet. In this study, it was found that transportation activity of MRP-2 decreased with increase in the number of alkyl chains of alkylphenols, suggesting that after MRP-2 recognizes or binds to the glucuronic acid anion, the long alkyl chain of alkylphenol-glucuronide disturbs the transportation across the membrane. The transporter, which mediates the transportation of glucuronides into the vein from liver cells, can transport only an ethylphenol-glucuronide having the shortest alkyl chain, indicating that metabolic distribution and excretion of alkylphenol is caused by the length of the alkyl chain. It has been shown that MRP-2 has transportation activity of glucuronide conjugates of various xenobiotics having large molecular mass (Yamazaki et al., 1996) , suggesting that inability of MRP-2 to transport nonylphenolglucuronide is due to the shape or hydrophobicity of the long (C9) alkyl chain.
Finally, nonylphenol has been shown to reduce the level of CYP1A1 expression in murine Hepa-1c1c7 cells (Jeong et al., 2001) and to inhibit in vitro CYP1A1 activity in rat liver microsomes (Lee et al., 1996) and activities of human cytochrome P450s, including steroidogeneic CYP17 activities (Niwa et al., 2002) . Oral administration of nonylphenol decreased hepatic testosterone hydroxylation and CYP2C expression level (Laurenzana et al., 2002) . Estradiol binding to the estradiol receptor (ER) was significantly inhibited by nonylphenol (Danzo, 1997) . These results suggest the possible inhibition of cytochrome P450s and ER functions by nonylphenol, which delays excretion from the liver.
FIG. 5. Excretion of alkylphenol metabolites during liver perfusion in EHBR.
A, excretion of metabolites of butylphenol and hexylphenol during a 1-h period of liver perfusion in EHBR, which have a hereditary defect in MRP-2. B, total amounts of the alkylphenols and glucuronide conjugates excreted into the bile and vein, and the total amount of those that remained in the liver during the 60-min period of liver perfusion. Numerals in the columns indicate the percentages of the respective metabolites (free, Ⅺ; or glucuronide conjugate, u). Parameters are shown as means Ϯ S.E. (n ϭ 4 animals).
One of the toxicological implications for the delay of excretion of nonylphenol and nonylphenol-glucuronide is estimated to the binding to and inhibition of ER (Tabira et al., 1999) ; another is the inhibition of MRP-2 which excretes various glucuronides such as estradiol glucuronide (Ito et al., 2001 ) and bilirubin glucuronide (Kusuhara et al., 1998) . The delay of nonylphenol excretion is possible because of the adverse effects of nonylphenol on rat reproductive systems (Laws et al., 2000) .
